SGLT2 inhibitors: major cardiovascular outcomes in ambulatory patients with HFrEF.

21 May 2022 (13:57 - 14:09)
Organised by:
Congress Presentation Part of: SGLT2 inhibitors across the spectrum of heart failure Chronic Heart Failure HFA Premium Access Heart Failure 2022